Thematics Asset Management Acquires 55,255 Shares of HealthEquity, Inc. $HQY

Key Points

• Thematics Asset Management increased its stake in HealthEquity, Inc. by 97.6% during the first quarter, holding approximately 111,842 shares valued at nearly $9.9 million after the purchase.
• Analysts are optimistic about HealthEquity's stock, with multiple firms raising their target prices, some reaching as high as $125.00, reflecting a consensus rating of "Buy."
• HealthEquity's recent earnings report exceeded estimates, with earnings per share of $0.97 against a consensus of $0.81, and a revenue of $330.8 million.

Thematics Asset Management increased its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 97.6% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 111,842 shares of the company's stock after purchasing an additional 55,255 shares during the period. Thematics Asset Management owned approximately 0.13% of HealthEquity worth $9,883,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the company. Comerica Bank boosted its position in HealthEquity by 43.4% during the 1st quarter. Comerica Bank now owns 70,153 shares of the company's stock valued at $6,199,000 after buying an additional 21,238 shares during the period. Axiom Investors LLC DE purchased a new stake in HealthEquity during the 1st quarter valued at $8,276,000. Penn Capital Management Company LLC purchased a new stake in HealthEquity during the 1st quarter valued at $1,013,000. Northwestern Mutual Wealth Management Co. boosted its position in HealthEquity by 176.4% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock valued at $58,000 after buying an additional 418 shares during the period. Finally, AlphaQuest LLC purchased a new stake in HealthEquity during the 1st quarter valued at $126,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In related news, Director Jon Kessler sold 97,767 shares of the business's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the completion of the sale, the director directly owned 75,000 shares in the company, valued at approximately $8,403,750. The trade was a 56.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the transaction, the executive vice president directly owned 75,689 shares in the company, valued at $8,519,553.84. This trade represents a 43.38% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is owned by company insiders.

HealthEquity Stock Performance

NASDAQ:HQY traded down $1.35 during trading hours on Wednesday, reaching $87.98. The company had a trading volume of 872,967 shares, compared to its average volume of 943,650. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. HealthEquity, Inc. has a 52 week low of $73.84 and a 52 week high of $116.65. The firm has a market cap of $7.61 billion, a price-to-earnings ratio of 64.22, a PEG ratio of 1.38 and a beta of 0.54. The firm's 50 day moving average price is $96.01 and its 200-day moving average price is $96.15.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The business had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same quarter in the previous year, the firm posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on HQY shares. The Goldman Sachs Group raised their target price on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. Raymond James Financial reaffirmed a "strong-buy" rating and issued a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Royal Bank Of Canada increased their price target on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft increased their price target on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. Finally, Bank of America raised their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $118.55.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.